Health CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD) July 24, 2026
Health MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease July 24, 2026
Health Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care July 23, 2026
Health [Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc July 23, 2026
Health K-Bro Announces Release Date, Conference Call and Webcast for Q2 2026 Financial Results July 23, 2026
Search
Health
July 25, 2026
July 24, 2026
July 24, 2026
July 24, 2026
July 23, 2026
July 23, 2026
July 23, 2026
July 23, 2026
![[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc](https://tradingwhisperer.com/wp-content/uploads/2026/07/b83b3ef8737509d112e004b64cdd5bce-1-336x223.jpg)
July 23, 2026
July 23, 2026
